Cargando…
An assessment of PCV13 vaccine coverage using a repeated cross-sectional household survey in Malawi
Background: The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in Malawi from November 2011 using a three dose primary series at 6, 10, and 14 weeks of age to reduce Streptococcus pneumoniae-related diseases. To date, PCV13 paediatric coverage in Malawi has not been rigorously asses...
Autores principales: | Bondo, Austin, Nambiar, Bejoy, Lufesi, Norman, Deula, Rashid, King, Carina, Masache, Gibson, Makwenda, Charles, Costello, Anthony, Rhoda, Dale, McCollum, Eric D., Colbourn, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266718/ https://www.ncbi.nlm.nih.gov/pubmed/30569035 http://dx.doi.org/10.12688/gatesopenres.12837.1 |
Ejemplares similares
-
Pulse oximetry for children with pneumonia treated as outpatients in rural Malawi
por: McCollum, Eric D, et al.
Publicado: (2016) -
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study
por: McCollum, Eric D., et al.
Publicado: (2017) -
Predicting Hospitalised Paediatric Pneumonia Mortality Risk: An External Validation of RISC and mRISC, and Local Tool Development (RISC-Malawi) from Malawi
por: Hooli, Shubhada, et al.
Publicado: (2016) -
Correction: Predicting Hospitalised Paediatric Pneumonia Mortality Risk: An External Validation of RISC and mRISC, and Local Tool Development (RISC-Malawi) from Malawi
por: Hooli, Shubhada, et al.
Publicado: (2018) -
Measurement and valuation of health providers’ time for the management of childhood pneumonia in rural Malawi: an empirical study
por: Bozzani, Fiammetta Maria, et al.
Publicado: (2016)